Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Ito

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Plos One|June 11, 2015
Predictive Modeling of Drug Response in Non-Hodgkin's LymphomaHermann B Frieboes, Bryan R Smith, Zhihui Wang, et al.
International Journal of Oncology|February 23, 2008
Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumorsNaoya Tatsumi, Yusuke Oji, Naoko Tsuji, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytesFumihiro Fujiki, Yoshihiro Oka, Akihiro Tsuboi, et al.
Scientific Reports|June 19, 2019
A landmark in drug discovery based on complex natural product synthesisSatoshi Kawano, Ken Ito, Kenzo Yahata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 19, 2026
Predictors of the early discontinuation of anamorelin hydrochloride in gastrointestinal cancer-related cachexia: a multicenter retrospective cohort study (HGCSG2201)Kazuaki Harada, Shinya Kajiura, Kentaro Sawada, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 4, 2026
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903)Yasuyuki Kawamoto, Kentaro Sawada, Kazuaki Harada, et al.
Cancer Science|October 27, 2004
Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumorsYusuke Oji, Tsuyoshi Suzuki, Yoko Nakano, et al.
Leukemia|November 27, 2023
Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolutionSakurako Suma, Yasuhito Suehara, Manabu Fujisawa, et al.
Pancreas|June 13, 2022
Analysis of the Pancreatic Cancer Microbiome Using Endoscopic Ultrasound-Guided Fine-Needle Aspiration-Derived SamplesShintaro Nakano, Yasuyuki Kawamoto, Yoshito Komatsu, et al.
Anticancer Research|October 30, 2004
Overexpression of the Wilms' tumor gene WT1 in esophageal cancerYusuke Oji, Masahiko Yano, Yoko Nakano, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Plos One|June 11, 2015
Predictive Modeling of Drug Response in Non-Hodgkin's LymphomaHermann B Frieboes, Bryan R Smith, Zhihui Wang, et al.
International Journal of Oncology|February 23, 2008
Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumorsNaoya Tatsumi, Yusuke Oji, Naoko Tsuji, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytesFumihiro Fujiki, Yoshihiro Oka, Akihiro Tsuboi, et al.
Scientific Reports|June 19, 2019
A landmark in drug discovery based on complex natural product synthesisSatoshi Kawano, Ken Ito, Kenzo Yahata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 19, 2026
Predictors of the early discontinuation of anamorelin hydrochloride in gastrointestinal cancer-related cachexia: a multicenter retrospective cohort study (HGCSG2201)Kazuaki Harada, Shinya Kajiura, Kentaro Sawada, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 4, 2026
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903)Yasuyuki Kawamoto, Kentaro Sawada, Kazuaki Harada, et al.
Cancer Science|October 27, 2004
Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumorsYusuke Oji, Tsuyoshi Suzuki, Yoko Nakano, et al.
Leukemia|November 27, 2023
Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolutionSakurako Suma, Yasuhito Suehara, Manabu Fujisawa, et al.
Pancreas|June 13, 2022
Analysis of the Pancreatic Cancer Microbiome Using Endoscopic Ultrasound-Guided Fine-Needle Aspiration-Derived SamplesShintaro Nakano, Yasuyuki Kawamoto, Yoshito Komatsu, et al.
Anticancer Research|October 30, 2004
Overexpression of the Wilms' tumor gene WT1 in esophageal cancerYusuke Oji, Masahiko Yano, Yoko Nakano, et al.
Pageof 17